Author:
Bassetti Matteo,Nicolini Laura,Repetto Ernestina,Righi Elda,Del Bono Valerio,Viscoli Claudio
Publisher
Springer Science and Business Media LLC
Reference15 articles.
1. Siegel JD, Rhinehart E, Jackson M, Chiarello L: Healthcare Infection Control Practices Advisory Committee. Management of multidrug-resistant organisms in health care settings, 2006. Am J Infect Control. 2007, 35 (10 Suppl 2): S165YS193
2. Hyle EP, Lipworth AD, Zaoutis TE, Nachamkin I, Bilker WB, Lautenbach E: Impact of inadequate initial antimicrobial therapy on mortality in infections due to extended-spectrum beta-lactamase-producing enterobacteriaceae: variability by site of infection. Arch Intern Med. 2005, 165: 1375-1380. 10.1001/archinte.165.12.1375.
3. Bratu S, Tolaney P, Karumudi U, Quale J, Mooty M, Nichani S, Landman D: Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY: molecular epidemiology and in itro activity of polymyxin B and other agents. J Antimicrob Chemother. 2005, 56: 128-32. 10.1093/jac/dki175.
4. Hawkey P, Finch R: Tigecycline: in-vitro performance as a predictorof clinical efficacy. Clin Microbiol Infect. 2007, 13: 354-62. 10.1111/j.1469-0691.2006.01621.x.
5. Babinchak T, Ellis-Grosse E, Dartois N, Rose GM, Loh E, Tigecycline 301 Study Group; Tigecycline 306 Study Group: The efficacy and safety of tigecycline for the treatment of complicated intraabdominal infections: analysis of pooled clinical trial data. Clin Infect Dis. 2005, 41: S354-67. 10.1086/431676.
Cited by
44 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献